Skip to main
PBM
PBM logo

PBM Market Capitalization Overview

Market Cap: $3.12M as of Jul 1, 2025

$3.12M
Past Month+$2.67M (597.87%)
As of Jul 1, 2025, PBM has a market capitalization of $3.12M. Over the past 30 days, its market cap has increased by 638.41%, while in the last 12 months, it has increased by 143.67%.

Market capitalization represents the total value of Psyence Biomedical Ltd as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

PBM Market Cap Formula = Stock Price * Shares Outstanding

The market cap of PBM helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

PBM Market Cap History

DateMarket CapChange
Jul 1, 2025$3.12M+638.41%
Jun 2, 2025$421.80K+58.21%
May 1, 2025$266.61K-25.68%
Apr 1, 2025$358.70K-42.52%
Mar 3, 2025$624.00K-29.45%
Feb 3, 2025$884.50K-29.81%
Jan 2, 2025$1.27M-35.60%

PBM End of Year Market Cap History

DateMarket CapChange
2025$3.12M+143.67%
2024$1.28M

FAQs About Psyence Biomedical Ltd (PBM) Market Cap

As of Jul 1, 2025, the market capitalization of PBM is $3.12M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Psyence Biomedical Ltd’s market capitalization has increased by 597.87%, changing from $446.30K to $3.12M as of Jul 1, 2025.

In the last 3 months, Psyence Biomedical Ltd’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Psyence Biomedical Ltd’s market capitalization increased from – in January to $1.28M in December, reflecting a — change.

Psyence Biomedical Ltd (PBM)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.